Skip to main content
GutCited
Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).
Figure 2. Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).

More Figures from This Paper

Figure 3

Figure 3
Figure 4

Figure 4
Figure 5

Figure 5
Figure 7

Figure 7
Figure 8

Figure 8
Figure 9

Figure 9

Figure 2

767 × 172px · 30,8 KB

Source Paper

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.

Pharmaceutics (2024)

PMID: 39339161

DOI: 10.3390/pharmaceutics16091123

Cite This Figure

![Figure 2: Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).](https://pdfs.citedhealth.com/figures/39339161/127.png)

> Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." *Pharmaceutics*, 2024. PMID: [39339161](https://pubmed.ncbi.nlm.nih.gov/39339161/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39339161/127.png" alt="Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6)." />
  <figcaption>Figure 2. Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).<br>  Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." <em>Pharmaceutics</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39339161/">39339161</a></figcaption>
</figure>

Evidências Relacionadas

C
N-Acetyl Cysteine (NAC) para Helicobacter pylori Infection

Nota C · 3 estudos